Organization and Summary of Significant Accounting Policies - Future Contingent Milestone and Royalty Assets (Details) - USD ($) $ in Thousands	1 Months Ended
	Feb. 28, 2025	Dec. 31, 2024	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Future contingent milestone and royalty assets		$ 144,200	$ 194,200
Royalty Pharma | Subsequent Events
Schedule of Equity Method Investments [Line Items]
Proceeds from milestone and royalty assets	$ 50,000
Royalty Pharma | Disposed of by Sale | TRC
Schedule of Equity Method Investments [Line Items]
Future contingent milestone and royalty assets		$ 144,200